Amid a backlash against foreign investors, some executives are banned from leaving the country
The Camry, last overhauled for the 2011 model year, just got another face-lift
Laws require companies to pay state taxes on sheltered profits
Financial filings reveal the pay package Henrique de Castro received upon exit from the company.
Wal-Mart's new money transfers shows how the retailer can use its reach to push down costs
Skipping Rocks Lab develops a green alternative to all that plastic
Alessandro Borgognone wooed Japanese chef Daisuke Nakazawa to open the four-star New York eatery
Administrators quashed their food delivery service. Now they're focusing on other colleges
Prices are low, but there’s plenty of red tape
Founders: Cam Garner, Elaine Phillips, Malcolm Hill, and Adam Simpson
VC Investment over the last four quarters: $22.5 million
Founded in 2008, this nine-employee drug company develops products for the treatment of allergic inflammation of the gastrointestinal tract. "We identified a market that we believe has a true unmet medical need—in this particular instance there is no product approved by the FDA for the treatment of eosinophilic esophagitis," says a Meritage spokesperson in an e-mail. In the midst of the recession, its founders say that it is particularly important to stay focused on execution.
Key to startup success: "If we are able to successfully develop safe and effective products to meet the unmet medical needs of patients and their caregivers, we believe that capital will continue to be available."